AzTrials
AzTrials

Depressive DisorderNCT02741622

Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.

A study testing High aerobic intensity training (HIT) and Long slow distance training (LSD) in people with Depressive Disorder and Depressive Disorder, Major, run by St. Olavs Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Acute aerobic exercise improves affective stats in patients with mental illnesses. Brain derived neurotropic factor (BDNF) may be a biological mechanism that contributes to the affective benefits. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
High aerobic intensity training (HIT) and Long slow distance training (LSD)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteNorway
Study dates
Mar 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Moderate or severe depression (ICD10: F32-F33)

Who cannot join

  • Bipolar disorder.

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • St.Olavs university Hospital, Departement of Østmarka

    Trondheim

Other trials in Norway

About this study

Official title: Effects of Aerobic Exercise Intensity on Affective States and Brain Derived Neurotropic Factor in Patients With Depression

Acute aerobic exercise improves affective stats in patients with mental illnesses. Brain derived neurotropic factor (BDNF) may be a biological mechanism that contributes to the affective benefits. The magnitude of the increase of serum BDNF might be exercise intensity dependent, but no study has compared low high-aerobic-intensity training at 90-95 % of the maximal heart rate (HRmax) with long-slow-distance training at 70 % of the HRmax in patients with depression.

The aim of this study is to compare changes in serum BDNF levels after high-aerobic-intensity training and long-slow-distance training in a intra-individual design in patients suffering from depression. The results will give indications of a possible difference in BDNF response between aerobic intensities and may be uses as pilot data for calculating sample size.

Being tested
High aerobic intensity training (HIT), Long slow distance training (LSD)
Keywords
Exercise therapy
Medical subject headings
Depressive Disorder, Depressive Disorder, Major

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High aerobic intensity training (HIT)Behavioural

    One training session, high aerobic intensity training (HIT) at 90-95 % of the maximal heart rate (HRmax)

  • Long slow distance training (LSD)Behavioural

    One training session, long slow distance training (LSD) at 70 % of the HRmax

Study groups in NCT02741622
Study groupRoleWhat they receive
ExerciseExperimentalAcute High aerobic intensity training (HIT) and long slow distance training (LSD)
Receives: Behavioral: High aerobic intensity training (HIT); Behavioral: Long slow distance training (LSD)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in serum brain derived neurotropic factor (BDNF)

    To measure serum BDNF levels, blood samples will be taken before and after each workout session.

    Measured: 15 minutes before exercise to 5> minutes after exercise.

Secondary outcomes (5)
  1. Change in affective symptoms

    The positive and negative affect schedule (PANAS) .

    Measured: 15 minutes before exercise to 15> minutes after exercise.

  2. Change in state of anxiety.

    A short form of state trait anxiety inventory for adults (STAI) is used to detect their state of anxiety.

    Measured: 15 minutes before exercise and 15> minutes after exercise.

  3. Change in subjective exercise experience

    The Subjective exercise experience scale (SEES).

    Measured: 15 minutes before exercise to 15> minutes after exercise.

  4. Maximal oxygen uptake

    Measured: Baseline

  5. Maximal Heart rate

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2016 (estimated)
  2. Study startMar 2016
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02741622
Sponsor's protocol ID
2015/2230
Status last verified
Dec 2018
First submitted
15 Mar 2016
Last updated
4 Dec 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing High aerobic intensity training (HIT) and Long slow distance training (LSD) in people with Depressive Disorder and Depressive Disorder, Major, run by St. Olavs Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Dec 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in serum brain derived neurotropic factor (BDNF) (time frame: 15 minutes before exercise to 5> minutes after exercise.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in